Tag Archives: Defective Drugs

Featured Stories

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...
Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Class III Voluntary Recall Issued for High Blood Pressure Medication

Class III Recall Issued for High Blood Pressure Medication

As a result of a recent Enforcement Report of the U.S. Food and Drug Administration (FDA), Sun Pharma and Lupin  are recalling over 41.5 thousand drug bottles in the United States. Sun Pharmaceutical Industries Inc. is recalling 12,109 bottles of … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs | Tagged , , , , , , |

FDA Requires Drug Interaction Studies for Kayexalate

FDA Requires Drug Interaction Studies for Kayexalate

The Food and Drug Administration (FDA) is requiring the manufacturer of the potassium-lowering drug Kayexalate to conduct studies to investigate Kayexalate’s potential to affect how other medications work. The approved labeling for Kayexalate (sodium polystyrene sulfonate) describes its potential to … Continue reading

Posted in Legal News, Pharmaceuticals | Tagged , , , |

FDA adds fatal skin rash warning to labels of hepatitis C drug

Several people who have taken the hepatitis C drug Incivek (telaprevir) recently developed a fatal skin condition that’s prompted a warning from federal regulators. According to a WebMD.com report this week, the Food and Drug Administration announced that people taking Incivek in … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , |

Kidney transplant rejections higher among those prescribed PPI acid-blockers

A retrospective study of kidney transplant patients found that those taking Proton Pump Inhibitor (PPI) drugs in conjunction with another drug in the year after their surgery were more likely to experience rejection. According to a report at RenalandUrologyNews.com on … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged , , |

CDC: 110 sick, 11 dead in fungal meningitis outbreak

There are now 110 confirmed cases of fungal meningitis that have been linked to a contaminated steroid injection given in the treatment of back pain. According to a MedPageToday.com update on the growing outbreak of fungal meningitis across the country, … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , |

Bisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”

Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team of medical experts issued this advisory when questioned about the use of these … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged , |

Johnson & Johnson Facilities at Center of Tylenol, Other Drug Recalls Face Greater FDA Scrutiny

A Johnson & Johnson drug plant in Fort Washington, Pennsylvania that made millions of bottles of recalled medicine, including < "http://www.yourlawyer.com/topics/overview/Tylenol-Liver-Damage-Injury-Lawsuit-Lawyer">Tylenol, Benadryl and Motrin, will not be allowed to reopen until the U.S. Food & Drug Administration (FDA) is assured … Continue reading

Posted in Acetaminophen / Tylenol, Pharmaceuticals | Tagged , , , , , , , |

Proton Pump Inhibitors in Early Pregnancy Associated with Heart Birth Defects

Using < "http://www.yourlawyer.com/topics/overview/Proton-Pump-Inhibitors-Birth-Defects-Septal-Lawsuit-Lawyer">proton pump inhibitors in the first trimester of pregnancy could increase the chance that a baby will be born with a cardiac defect. In a 2010 retrospective study of over 200,000 women, those using proton pump inhibitors were … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , |

Use of Prevnar, ActHIB Vaccines Halted in Japan After Child Deaths

Four children have died in Japan after being vaccinated with < "http://www.yourlawyer.com/practice_areas/defective_drugs">Prevnar and ActHIB. According to the Wall Street Journal, the Japanese government has stopped use of these vaccines and, now, international health authorities are looking into potential side effects … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , |

NSAID Side Effects Could Include Erectile Dysfunction

< "http://www.yourlawyer.com/practice_areas/defective_drugs">NSAIDs—nonsteroidal anti-inflammatory drugs— previously been linked to increased stroke and heart attack risks, have now been connected with erectile dysfunction (ED) with regular use, says MedScape. The emerging study, a prospective cohort, appeared online last month and in the … Continue reading

Posted in Legal News | Tagged , , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.